Adherence to HAART among HIV-infected persons in rural Louisiana

被引:38
作者
Mohammed, H
Kieltyka, L
Richardson-Alston, G
Magnus, M
Fawal, H
Vermund, SH
Rice, J
Kissinger, P
机构
[1] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA
[2] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA
关键词
D O I
10.1089/108729104323076025
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The purpose of this study was to examine factors associated with nonadherence to highly active antiretroviral therapy (HAART) in patients seen in HIV clinics throughout nonurban Louisiana. A convenience sample of 273 patients from 8 areas in nonurban Louisiana were interviewed to obtain demographic, clinical and adherence information. Associations between demographic, clinical, and behavioral factors and nonadherence were examined. Ideally, nonadherence should not exceed 5% in patients for whom HAART was prescribed. Mean age was 38.6 years (range, 19-66), 29.3% were female, 60.1% were African American, 34.4% reported nonadherence to their HAART medication (defined as the subject's self-report of missing any doses of HAART medication in the prior week). In the prior month, participants reported the following behaviors: binge drinking (12.8%), problem drinking (12.8%), and illicit drug use (16.5%). Depression was found in 49.8% of the respondents. In logistic regression analysis, problem drinking odds ratio [OR] (95% confidence interval [CI]): 3.92 (1.69,9.09) was found to be associated with nonadherence. Demographic and behavioral factors such as illicit drug use and depression were not associated with nonadherence on multivariable analysis. Problem drinking was associated with lack of adherence to HAART over the past week. Interventions to treat problem drinking are needed and may improve adherence to medication for HIV-infected persons living in rural, town, and small-city areas.
引用
收藏
页码:289 / 296
页数:8
相关论文
共 31 条
[1]  
Akukwe C, 2001, J Health Soc Policy, V12, P1, DOI 10.1300/J045v12n03_01
[2]   HIV AIDS in nonurban Alabama: Risk activities and access to services among HIV-infected persons [J].
Beltrami, JF ;
Vermund, SH ;
Fawal, HJ ;
Moon, TD ;
Von Bargen, JC ;
Holmberg, SD .
SOUTHERN MEDICAL JOURNAL, 1999, 92 (07) :677-683
[3]  
Chesney MA, 1999, AIDS, V13, pS271
[4]   HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression [J].
Davey, RT ;
Bhat, N ;
Yoder, C ;
Chun, TW ;
Metcalf, JA ;
Dewar, R ;
Natarajan, V ;
Lempicki, RA ;
Adelsberger, JW ;
Millers, KD ;
Kovacs, JA ;
Polis, MA ;
Walker, RE ;
Falloon, L ;
Masur, H ;
Gee, D ;
Baseler, M ;
Dimitrov, DS ;
Fauci, AS ;
Lane, HC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (26) :15109-15114
[5]  
DiClemente RJ, 2002, SOUTH MED J, V95, P421, DOI 10.1097/00007611-200204000-00009
[6]   Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters [J].
Dybul, M ;
Chun, TW ;
Yoder, C ;
Hidalgo, B ;
Belson, M ;
Hertogs, K ;
Larder, B ;
Dewar, RL ;
Fox, CH ;
Hallahan, CW ;
Justement, JS ;
Migueles, SA ;
Metcalf, JA ;
Davey, RT ;
Daucher, M ;
Pandya, P ;
Baseler, M ;
Ward, DJ ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :15161-15166
[7]   Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease [J].
Eldred, LJ ;
Wu, AW ;
Chaisson, RE ;
Moore, RD .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1998, 18 (02) :117-125
[8]  
ERWIN J, 1998, INT ANTIVIRAL NEWS, V6, P12
[9]  
FARAGON JJ, 2003, AIDS READ, V13, P446
[10]  
Faragon JJ, 2003, AIDS READ, V13, P437